3D Imaging Detection of HER2 Based in the Use of Novel Affibody-Quantum Dots Probes and Ratiometric Analysis

Patients with breast cancer (BC) overexpressing HER2 (HER2+) are selected for Trastuzumab treatment, which blocks HER2 and improves cancer prognosis. However, HER2+ diagnosis, by the gold standard, immunohistochemistry, could lead to errors, associated to: a) variability in sample manipulation (thin...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Treviño, Perla, la Cerda, Héctor Hernández-De, Pérez-Treviño, Jorge, Fajardo-Ramírez, Oscar Raúl, García, Noemí, Altamirano, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053773/
https://www.ncbi.nlm.nih.gov/pubmed/29627705
http://dx.doi.org/10.1016/j.tranon.2018.03.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053773/
https://www.ncbi.nlm.nih.gov/pubmed/29627705
http://dx.doi.org/10.1016/j.tranon.2018.03.004

Ejemplares similares